AlveoliX AG

AlveoliX AG

Private
BernHealthcare & Life Scienceshttps://www.alveolix.com/

Last Round

Grant

Oct 1, 2024

Total Funding Raised

$2.07M

Momentum Score

50 /100

Company Overview

AlveoliX AG is a life sciences platforms and tools company that provides organ-on-chip in-vitro solutions aimed at improving preclinical decision-making.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotech Equipment, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Hardware + Subscription

AI Layer

Non-AI

Keywords

organ-on-chipOoClung-on-chipmicrophysiological systemsMPSpreclinical modelsanimal testing alternativein-vitro modelsdrug discoverymicrofluidicsbreathing simulation3Rs animal testingtoxicology testingdisease modelingbiotech equipmentcontract research organizationCROsafety assessment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AlveoliX AG Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AlveoliX AG Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantOct 1, 2024
GrantJun 14, 2022
GrantMay 1, 2021
GrantMar 19, 2019
GrantFeb 1, 2016
Grant
Jan 13, 2015

Key People

Founding team and executive leadership

Andreas Hugi

CTO

Executive Team

AlveoliX AG Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    Monthly visitors grew 88% MoM, from 747 to 1.4K.

  • Jul 19, 2025

    Grew 27% QoQ, from 11 to 14 employees.

AlveoliX AG Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AlveoliX AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AlveoliX AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersBern
Employee Range14
Year Founded2015
Last FundingOct 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.